Stay updated on Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Sign up to get notified when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.

Latest updates to the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision was updated from v3.4.1 to v3.4.2. No visible content changes were made to the study details.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision note updated from v3.4.0 to v3.4.1. There are no changes to the study details, eligibility criteria, or results displayed on this page.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page shows a revision label update from v3.4.0 to v3.4.1. The new label appears as 'Revision: v3.4.1' and the old label 'Revision: v3.4.0' is removed.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed as part of administrative site updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe study Locations section was updated to reflect changes in site availability, adding new locations (South Australia, Western Australia, Nova Scotia, Ontario) and removing others, and the page revision was updated to v3.3.3.SummaryDifference0.4%

Stay in the know with updates to Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.